COVID-19: Ensitrelvir schützt Kontakte im Haushalt vor Erkrankung Charlottesville – Eine 5-tägige Behandlung mit dem Virusblocker Ensitrelvir, der bisher nur in Japan und Singapur zugelassen ist, hat in einer randomisierten Studie das Risiko einer…

Lessons from COVID-19 for improving delivery of medications for opioid use disorder in future pandemic events: results from a Puerto Rico Delphi consensus panel.  Abadie R, Fisher C.  Harm Reduct J. 2026 Apr 19. doi: 10.1186/s12954-026-0…

Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: A population-based interrupted time series analysis.  Young S, Raboud J, Dodd Z, Barnett-Tapia C, Gomes T, Fairbairn N, Bayoumi AM.  Int J Drug Policy…

Using Routinely Collected Data From the Network of Alcohol and Other Drugs Agencies Database to Evaluate the Impact of COVID-19 Lockdowns on Trends in Service Delivery in Outpatient Non-Government Alcohol and Other Drug Treatment Services.  Be…

At last, a pill that can prevent COVID after exposure to infected people Drug arrives years after pandemic’s peak, but could still offer protection to vulnerable populations. (Nature News, USA, 13.05.2026, Anmeldung erforderlich) https://www.natur…

Fear of COVID-19 over the first year of the pandemic: Effect on anxiety, depression, and substance use, taking mental health support into account.  Burstyn I, Huỳnh TB.  Glob Epidemiol. 2026 Apr 26;11:100262. doi: 10.1016/j.gloepi.2026.1…